Breaking News
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
November 19, 2018 - Systemic mastocytosis – Genetics Home Reference
November 19, 2018 - Eye trauma secondary to falls in older adults increasing
November 19, 2018 - Empowering women in India to improve their health: A Q&A
November 19, 2018 - Researchers have trained a computer to analyze breast cancer images and classify tumors
November 19, 2018 - New glucose binding molecule could be key to better metabolic control for diabetics
November 19, 2018 - Biologists uncover novel genetic control of lipid maintenance and its potential connection to lifespan
November 19, 2018 - Warmer winters may set scene for higher rates of violent crimes
November 19, 2018 - Acacia Pharma Resubmits Barhemsys New Drug Application
November 19, 2018 - PDL1 (Immunotherapy) Tests: MedlinePlus Lab Test Information
November 19, 2018 - Transforming pregnancy research with a smartphone app
November 19, 2018 - Stanford Medicine magazine explores how digital technology is changing health care
November 19, 2018 - Marijuana prevention programs should focus on promoting mental wellbeing of youth
November 19, 2018 - New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation
November 19, 2018 - In throes of turkey salmonella outbreak, don’t invite illness to your table
November 19, 2018 - UK health policies should be redesigned to become more accessible for men
November 19, 2018 - Short Interpregnancy Intervals Tied to Adverse Outcome Risk
November 19, 2018 - New mothers’ breastfeeding pain can affect infant health
November 19, 2018 - Stanford Medicine magazine reports on ways digital technology is transforming health care | News Center
November 19, 2018 - Human drugs alter cricket personality
November 19, 2018 - Insilico Medicine to introduce ‘Cure a disease in a year’ program at Biodata World Congress 2018
November 19, 2018 - Experts debate over whether gut or brain is more important in regulating appetite
November 19, 2018 - Playing on fear and fun, hospitals follow pharma in direct-to-consumer advertising
November 19, 2018 - 2PG Company receives grant to develop sensitive, low-cost molecular diagnostic tests for tuberculosis
November 19, 2018 - Low-Carb Diets May Work By Boosting Calorie Burn
November 19, 2018 - Key molecule responsible for learning and memory discovered
November 19, 2018 - New blood test developed for early diagnosis of ovarian cancer
November 19, 2018 - Researchers identify molecule to fight myotubular myopathy
November 19, 2018 - New solution to stop spread of brain cancer
November 19, 2018 - Immune cells trigger OCD-like behaviour in multiple sclerosis, study finds
November 19, 2018 - Scientists equip new virus that kills carcinoma cells with protein
November 19, 2018 - Novel approach could provide painless, efficient alternative for treating eye diseases
November 19, 2018 - Protein in cell membranes of sperm plays key role in finding their way to eggs
November 19, 2018 - Parents who decline flu vaccination for their child may be exposed to limited information
November 19, 2018 - Mirati Presents Data From Ongoing Phase 2 Clinical Trial Of Mocetinostat In Combination With Durvalumab At The SITC 33rd Annual Meeting
November 19, 2018 - FDA warns of common diabetes meds’ link to dangerous genital infection
November 19, 2018 - New methods for preserving shoulder function, quality of life in breast cancer patients
November 19, 2018 - Surprising discovery about BH4 may rekindle interest in once-promising pathway
November 19, 2018 - Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections
November 19, 2018 - Beating breast cancer only to die of opioid use – a sad Appalachian story
November 19, 2018 - Workplace bullying or violence linked to higher risk of cardiovascular problems
November 19, 2018 - Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
November 19, 2018 - ‘Game-changing’ skin sensor could improve life for a million hydrocephalus patients
November 19, 2018 - Alcohol ads on social media sites with pro-drinking comments increase desire to drink
November 19, 2018 - Neural networks could replace marker genes in RNA sequencing
November 19, 2018 - Obese adolescents feel less food enjoyment than those with normal weight, study reveals
November 18, 2018 - Goodbye ‘Gluten-Free’? Celiac Disease Vaccine May Make It Possible
November 18, 2018 - Skin ages when the main cells in the dermis lose their identity and function
November 18, 2018 - Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
November 18, 2018 - A new mechanism in the control of inflammation
November 18, 2018 - Age-related decline in abstract reasoning ability predicts depressive symptoms over time
November 18, 2018 - Scientists succeed in increasing stability, biocompatibility of light-transducing nanoparticles
November 18, 2018 - Sugar, a ‘sweet’ tool to understand brain injuries
November 18, 2018 - Pharmacist-Led Effort Cuts Inappropriate Rx in Older Adults
November 18, 2018 - Novel discovery could lead to new cancer, autoimmune disease therapy
November 18, 2018 - AHA and ADA launch new initiative to help people with type 2 diabetes reduce heart disease risk
November 18, 2018 - Balanced production of pro and anti-inflammatory cytokines at two years of age protects against malaria
November 18, 2018 - New pharmacological agent shows promise for prevention of heart rhythm disorders
November 18, 2018 - All That Social Media May Boost Loneliness, Not Banish It
November 18, 2018 - Scientists shine new light on link between obesity and cancer
November 18, 2018 - Risk factors for cardiovascular disease closely track with changes in diet patterns
November 18, 2018 - Biogen Scoops Sixth Prix Galien Award with UK Win for Life-Changing Rare Disease Medicine
November 18, 2018 - Detectable HIV-1 in treated human liver cells found to be inert
November 18, 2018 - Using light to control crucial step in embryonic development
November 18, 2018 - Unusual case of father-to-son HIV transmission reported
November 18, 2018 - FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
November 18, 2018 - Poverty blamed on widening north-south gap in young adult deaths in England
November 18, 2018 - Progress in meningitis lags far behind other vaccine-preventable diseases, analysis shows
November 18, 2018 - Consensus Statement Issued on Management of Foot, Ankle Gout
November 18, 2018 - Fine particle air pollution is a public health emergency hiding in plain sight
November 18, 2018 - In-hospital mortality higher among patients with drug-resistant infections
November 17, 2018 - Research shines new, explanatory light on link between obesity and cancer
November 17, 2018 - FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings
November 17, 2018 - Tracking Preemies’ Head Size May Yield IQ Clues
November 17, 2018 - Scientists call for unified standards in 3-D genome and epigenetic data
November 17, 2018 - Lab Innovations 2018 has beaten all records by attracting 3,113 attendees
November 17, 2018 - New strategy to hinder emergence of antimicrobial-resistant pathogens
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Reducing cellular proliferation could help deplete HIV reservoir and lead to a functional cure
November 17, 2018 - New model of FSHD could be useful to study effectiveness of experimental therapeutics

Health leaders reveal ten most important medicines in NHS history

image_pdfDownload PDFimage_print

Health experts in the UK have identified what they believe to be the ten most important and impactful medicines and vaccines introduced in to the NHS in the past 70 years.

Among the top ten are two vaccines – those which prevent polio and measles, mumps and rubella – as well as medicines which have transformed HIV/AIDS from a death sentence to a manageable condition, immunosuppressants which paved the way for successful transplants, and antipsychotics that led the way for all modern treatment of mental health conditions including depression, schizophrenia and bipolar disorder.

The findings are published in a new report from OHE Consulting Ltd and commissioned by the Association of the British Pharmaceutical Industry (ABPI). The report celebrates the contribution of medicines and vaccines to the NHS in the year the NHS turns 70.

The report demonstrates through interviews with several leading health experts1, including pharmacists, clinicians and scientists, the contribution and impact of medicines based on health and economic outcomes and impact on the healthcare environment. The medicines were chosen from a long list of 37.

The top ten medicines and vaccines are:

Chlorpromazine (Year of launch: 1953)

Chlorpromazine was the first antipsychotic, synthesised in 1951 and first used in the NHS in 1954. It is seen as fundamental in the ‘psychopharmacological revolution’ and paved the way for deinstitutionalisation and community-based care for people with mental illness. It gave rise to all modern antipsychotic and antidepressant medications and is still included in the WHO Model List of Essential Medicines.

Polio vaccine (Year of launch: 1955)

Responsible for eradicating polio in the UK within 11 years of its introduction and predicted to have saved 10,000 lives between 1958 and 2018.

Oral contraceptives (Year of launch: 1961)

‘The pill’ was one of the first medicinal products to be taken daily by millions of healthy people, creating new dynamics in the consideration of the risks and benefits of pharmaceutical products.

Oral contraception was identified by interviewees as having had an important health, economic, and broader social impact in the UK. It has been described as the medical development with perhaps the greatest ‘non-medical’ consequences.

Second to fourth generation penicillins (Year of launch: 1961)

Despite current concerns about antimicrobial resistance and overuse of antibacterial agents, antibiotics are regularly cited as one of the most important developments in the history of medicine.

Beta Blocker (Year of launch: 1965)

Used to treat heart disease, there is strong evidence that patients receiving beta blockers experience a relative risk reduction in mortality of around 35%, with an absolute difference in death rates of around 5%.

Beta2 agonists (Year of launch: 1969)

In the UK in the mid-1960s, three in every 100,000 people aged 15-44 died because of asthma. A decade later, that rate had fallen below one per 300,000. The shift can be attributed in large part to anti-asthma agents like Beta2 agonists.

Tamoxifen (Year of launch: 1972)

Breast cancer care has undergone major changes over the history of the NHS, including surgery, radiotherapy, hormonal and cytotoxic treatment, and screening by mammography. First available in the UK in 1972, tamoxifen was cited by some interviewees as a key development in breast cancer care with major health impact.

The availability of the medicine was part of the justification for the introduction of a national screening programme in 1988, after which breast cancer mortality rates declined significantly.

Immunosuppressants (Year of launch: 1972)

Immunosuppressive medications facilitated successful organ transplant in the 1960s. A breakthrough for modern transplant surgery happened in 1983 with the introduction of cyclosporin.

The first successful heart-lung transplant in the UK was conducted in 1983; 1985 saw Britain’s youngest liver transplant patient; and in 1986 the world’s first liver, heart and lung transplant was successfully completed in Cambridge. Immunosuppressants were cited by interviewees as significantly reducing the burden on the NHS through reducing the rate of transplant rejection.

HIV/AIDS antiretrovirals

Zidovudine was the first treatment for human immunodeficiency virus (HIV). Interviewees pointed to zidovudine and other antiretroviral treatments for HIV as having prevented an acquired immune deficiency syndrome (AIDS) pandemic that could have overwhelmed the NHS.

Subsequent developments in the treatment of HIV, including combined antiretroviral therapy (cART), have achieved major gains in morbidity and mortality. cART has been shown to reduce mortality by 50%.

MMR vaccine

In 1948, there were almost 400,000 cases of measles in the UK, and 327 people died. In 1968, a measles vaccine was introduced, and the number of cases and deaths fell dramatically. 1994 was the first year without a measles death. By 2015 the number of cases of measles in the UK stood at 1,200.

The long list of 37 medicines can be found here.

Speaking about the research, Dr Sheuli Porkess, Deputy Scientific Officer at the ABPI, said:

“The discovery of ground-breaking medicines and their introduction in to the NHS had been transformational for patients. For 70 years, our industry – working alongside the NHS – has seen life-threatening diseases cured or become manageable conditions, including cancers, heart disease and HIV.

“In 70 years-time I hope we will be celebrating how advances in exciting new research in genetics, artificial intelligence and personalised medicines have helped to cure and treat many more complex diseases.”

Report author, Paula Lorgelly, said:

“The milestone of the NHS turning 70 provides an opportunity for us to consider the impact of medicines to the success of the NHS. “As well as identifying a short list of influential and often overlooked medicines, we also identified factors that aided their impact. These included the value of innovation, complementarity and scientific spillovers, substitution, the evidence base, aiding understanding, active collaboration and supportive health policy. These factors are important to consider to ensure new and future medicine developments continue to deliver impact to the NHS.”

Tagged with:

About author

Related Articles